Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France ; volume:18 ; number:1 ; day:19 ; month:2 ; year:2021 ; pages:1-3 ; date:12.2021
Harm reduction journal ; 18, Heft 1 (19.2.2021), 1-3, 12.2021
- Classification
-
Soziale Probleme, Sozialdienste, Versicherungen
- Creator
-
Mezaache, Salim
Carrieri, Patrizia
Briand‑Madrid, Laelia
Laporte, Virginie
Morel, Alain
Castro, Daniela Rojas
Roux, Perrine
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-021-00465-9
- URN
-
urn:nbn:de:101:1-2021040823422378171975
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mezaache, Salim
- Carrieri, Patrizia
- Briand‑Madrid, Laelia
- Laporte, Virginie
- Morel, Alain
- Castro, Daniela Rojas
- Roux, Perrine
- SpringerLink (Online service)
Other Objects (12)
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial
Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Physicians’ satisfaction with providing buprenorphine treatment
Buprenorphine—Clinically useful but often misunderstood
Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial
Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Physicians’ satisfaction with providing buprenorphine treatment
Buprenorphine—Clinically useful but often misunderstood
Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?
Individual and structural correlates of willingness for intravenous buprenorphine treatment among people who inject sublingual buprenorphine in France
Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine
Postoperative respiratory depression in patients on sublingual buprenorphine: a retrospective cohort study for comparison between postoperative continuation and discontinuation of buprenorphine
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial
Sublingual Buprenorphine Efficacy in Renal Colic Pain Relief: A Randomized Placebo-Controlled Clinical Trial
Population Pharmacokinetic Analysis Supports Initiation Treatment and Bridging from Sublingual Buprenorphine to Subcutaneous Administration of a Buprenorphine Depot (CAM2038) in the Treatment of Opioid Use Disorder
Safety and effectiveness of Buprenorphine-Naloxone sublingual tablet in the treatment of opioid use disorder
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Physicians’ satisfaction with providing buprenorphine treatment
Buprenorphine—Clinically useful but often misunderstood